Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Cameron

Showing results (251-260 of 286) with videos related to

Pageof 29
Sort By:
Chinese Clinical Oncology|June 25, 2020
Radical antegrade modular pancreatosplenectomy versus standard distal pancreatosplenectomy for pancreatic cancer, a dual-institutional analysisJonathan G Sham, Shiwei Guo, Ding Ding, et al.
Annals of Surgery|July 20, 2016
Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the PancreasAntonio Pea, Jun Yu, Neda Rezaee, et al.
Annals of Surgical Oncology|August 27, 2021
Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic CancerGeorgios Gemenetzis, Alex B Blair, Minako Nagai, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2024
Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic Ductal AdenocarcinomaColin S Hill, Rose Parkinson, Elizabeth M Jaffee, et al.
Annals of Surgical Oncology|January 8, 2015
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution ExperienceShalini Moningi, Avani S Dholakia, Siva P Raman, et al.
Annals of Surgery|May 15, 2019
Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 PatientsGeorgios Antonios Margonis, Stefan Buettner, Nikolaos Andreatos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancerChristine A Iacobuzio-Donahue, Baojin Fu, Shinichi Yachida, et al.
Annals of Surgery|January 13, 2016
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic AdenocarcinomaKatherine E Poruk, Vicente Valero, Tyler Saunders, et al.
The American Journal of Pathology|March 26, 2003
Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarraysChristine A Iacobuzio-Donahue, Anirban Maitra, Mari Olsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins HospitalJoseph M Herman, Michael J Swartz, Charles C Hsu, et al.
Pageof 29

Showing results (251-260 of 286) with videos related to

Sort By:
Pageof 29
Chinese Clinical Oncology|June 25, 2020
Radical antegrade modular pancreatosplenectomy versus standard distal pancreatosplenectomy for pancreatic cancer, a dual-institutional analysisJonathan G Sham, Shiwei Guo, Ding Ding, et al.
Annals of Surgery|July 20, 2016
Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the PancreasAntonio Pea, Jun Yu, Neda Rezaee, et al.
Annals of Surgical Oncology|August 27, 2021
Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic CancerGeorgios Gemenetzis, Alex B Blair, Minako Nagai, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2024
Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic Ductal AdenocarcinomaColin S Hill, Rose Parkinson, Elizabeth M Jaffee, et al.
Annals of Surgical Oncology|January 8, 2015
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution ExperienceShalini Moningi, Avani S Dholakia, Siva P Raman, et al.
Annals of Surgery|May 15, 2019
Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 PatientsGeorgios Antonios Margonis, Stefan Buettner, Nikolaos Andreatos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancerChristine A Iacobuzio-Donahue, Baojin Fu, Shinichi Yachida, et al.
Annals of Surgery|January 13, 2016
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic AdenocarcinomaKatherine E Poruk, Vicente Valero, Tyler Saunders, et al.
The American Journal of Pathology|March 26, 2003
Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarraysChristine A Iacobuzio-Donahue, Anirban Maitra, Mari Olsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins HospitalJoseph M Herman, Michael J Swartz, Charles C Hsu, et al.
Pageof 29